Journal of Pharmacy And Bioallied Sciences · 2012 · 30 citations · 2 references
PharmacyPharmaceuticsPharmacologyBioavailabilityDrug DeliveryPharmaceutical FormulationDrug SolubilityEmulsion FormulationFormulation Effects On BioavailabilityOral Bioavailability EnhancementSolubility EnhancementSolubility OptimizationDrug Solubility ScreeningDye SolubilityMicroemulsion SynthesisSolubilitySolubilization By SurfactantsSurfactant Solubilization
Cilnidipine, a calcium channel blocker having neuroprotective action and BCS Class II drug, hence formulating in Microemulsion will increase solubility, absorption and bioavailability. The formulation was prepared using titration method by tocotrienol, tween 20 and transcutol HP as oil, surfactant and co-surfactant and characterized for dilutability, dye solubility, assay (98.39±0.06), pH (6.6±1.5), Viscosity (98±1.0 cps) and Conductivity (0.2±0.09 μS/cm). The formulation was optimized on basis of percentage transmittance (99.269±0.23 at 700 nm), Globule size (13.31±4.3 nm) and zeta potential (-11.4±2.3 mV). Cilnidipine microemulsion was found to be stable for 3 months.
2
Cilnidipine: Preclinical Profile and Clinical Evaluation
Hisayuki Uneyama, Hirohisa Uchida, Tomoyuki Konda et al. · Cardiovascular Drug Reviews · 1999 · 34 citations